Skip to content
healthcare.dev

AKYNZEO

NDC 69639-106, Fosnetupitant and Palonosetron, injection, from Helsinn Therapeutics (U.S.), Inc..

Product NDC
69639-106
Status
Listed
Labeler
Helsinn Therapeutics (U.S.), Inc.
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA210493
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69639-106 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • FOSNETUPITANT260 mg/20mL
  • PALONOSETRON HYDROCHLORIDE.28 mg/20mL

Pharmacologic classes

Serotonin 3 Receptor Antagonists [MoA]; Serotonin-3 Receptor Antagonist [EPC]

Package NDCNDC-11Package
69639-106-01696390106011 VIAL, SINGLE-DOSE in 1 CARTON (69639-106-01) / 20 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/8e47618e-af46-4d82-94e8-1507c042252d
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=69639-106

Use it

Look up 69639-106 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69639-106 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69639-106. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.